Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.20.2
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Expenses    
Research and development expenses, net of government assistance $ (15,974) $ (29,373)
General and administrative expenses (5,799) (4,539)
Sales and marketing (2,665) (494)
Loss from operations (24,438) (34,406)
Financial expenses (1,075) (4,960)
Net loss and total comprehensive loss $ (25,513) $ (39,366)
Basic and diluted loss per share (in dollars per share) $ (0.30) $ (0.73)
Weighted average number of shares outstanding (in shares) 84,581,764 54,290,295